Skip to content

Clinical trials

Phase 1/2 Neoplasm Metastasis trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasm Metastasis Phase: Phase 1/2 Country / region: France Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20101
20112
20123
20131
20142
20164
20171
20183
20204
20214
20226
20235
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15
Completed10
Active, not recruiting9
Terminated9
Unknown status2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals4
AstraZeneca3
Ipsen2
Merck Sharp & Dohme LLC2
Nuvalent Inc.2
Anaveon AG1
Array BioPharma1
Artios Pharma Ltd1
Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie1
BBB-Therapeutics B.V.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasm Metastasis46
Carcinoma, Non-Small-Cell Lung12
Breast Neoplasms9
Neoplasms8
Colorectal Neoplasms6
Melanoma6
Sarcoma6
Triple Negative Breast Neoplasms6
Lung Neoplasms4
Recurrence4

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.